About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited ("CSPC") is a distinguished pharmaceutical organization in China, renowned for its dedication to innovation and excellence in the healthcare sector. Established in 1994, CSPC has established a strong presence in the industry and has achieved significant milestones over the years. Listed on the Main Board of the Hong Kong Stock Exchange, CSPC has solidified its position as a leading player in the market.

In 2018, the company made history by becoming the first constituent stock in the pharmaceutical sector to be included in the prestigious Hang Seng Index. CSPC is also a constituent stock of various other key indices, including the "Hang Seng Composite Index", "Hang Seng Healthcare Index", and "Hang Seng China Enterprises Index", among others. CSPC's business operations are divided into two key segments: finished drugs and bulk drugs, with a focus on innovative drug development.

The company boasts a robust product portfolio that encompasses therapeutic areas such as nervous system diseases, oncology, anti-infectives, and cardiovascular diseases. Some of CSPC's most popular innovative drug products in China include "NBP", "Domeisu", "Jinyouli", "Keaili", and "Xuanning". In addition to its pharmaceutical offerings, CSPC also manufactures bulk drug products, including vitamin C, antibiotics, and caffeine series.

The company's state-of-the-art manufacturing facilities are primarily based in Shijiazhuang City, Hebei Province, China. CSPC prides itself on its international R&D team, with research and development bases in China and the United States. The team focuses on the discovery and development of small molecule targeted drugs, nano-drugs, monoclonal antibody drugs, and biological drugs in the immune field, among others.

Recognized for its excellence, the "CSPC" brand has consistently been ranked among the "Top 500 Most Valuable Brands in China" by the World Brand Lab for over a decade. Regarding corporate social responsibility, CSPC is actively involved in supporting social welfare charities and has participated in numerous philanthropic initiatives such as disaster relief campaigns and services for children with critical illnesses.

The company remains committed to making positive contributions to society through meaningful actions and initiatives. CSPC's commitment to innovation, quality, and social responsibility has solidified its reputation as a trusted leader in the pharmaceutical industry, setting it apart as a beacon of excellence and integrity.

Growth

CSPC Pharmaceutical Group Limited is an established enterprise in the pharmaceutical industry, with a strong presence in the market and a history of steady growth and development. The company has reached a mature stage in its evolution, positioning itself as a key player in the healthcare sector with a global footprint. It continues to expand its product portfolio and market share through strategic initiatives and partnerships.

Recent News

Achievements

CSPC Pharmaceutical Group Limited has achieved significant milestones in its history, including consistent revenue growth year over year, successful market penetration in key regions, and expansion of its customer base. The company's key products, such as finished drugs and bulk drugs, have gained widespread recognition, contributing to its overall success in the industry.

Case Studies

CSPC Pharmaceutical Group Limited has been involved in several noteworthy case studies and projects that have had a significant impact on the industry. These initiatives have demonstrated the company's ability to innovate, collaborate with industry partners, and meet the evolving needs of healthcare consumers. From the development of new drug formulations to the expansion of manufacturing capabilities, CSPC Pharmaceutical Group Limited continues to drive positive change in the pharmaceutical sector.

Experience

Education

Socials

Similar Companies